Hennion & Walsh Asset Management’s Immunocore IMCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
66,780
+4,225
| +7% | +$133K | 0.08% | 308 |
|
|
2025
Q1 | $1.86M | Buy |
62,555
+12,947
| +26% | +$384K | 0.08% | 290 |
|
|
2024
Q4 | $1.46M | Buy |
49,608
+27,598
| +125% | +$814K | 0.07% | 367 |
|
|
2024
Q3 | $685K | Sell |
22,010
-612
| -3% | -$19.1K | 0.03% | 540 |
|
|
2024
Q2 | $767K | Buy |
22,622
+1,390
| +7% | +$47.1K | 0.04% | 485 |
|
|
2024
Q1 | $1.38M | Buy |
21,232
+8,848
| +71% | +$575K | 0.07% | 340 |
|
|
2023
Q4 | $846K | Buy |
+12,384
| New | +$846K | 0.05% | 444 |
|